G
Giuseppe Mancia
Researcher at University of Milano-Bicocca
Publications - 1465
Citations - 152794
Giuseppe Mancia is an academic researcher from University of Milano-Bicocca. The author has contributed to research in topics: Blood pressure & Ambulatory blood pressure. The author has an hindex of 145, co-authored 1369 publications receiving 139692 citations. Previous affiliations of Giuseppe Mancia include University of Milan & Instituto Politécnico Nacional.
Papers
More filters
Journal ArticleDOI
Cardiovascular Risk Reduction After Renal Denervation According to Time in Therapeutic Systolic Blood Pressure Range.
Felix Mahfoud,Giuseppe Mancia,Roland E. Schmieder,Luis M. Ruilope,Krzysztof Narkiewicz,Markus P. Schlaich,Bryan Williams,Flavio Ribichini,Joachim Weil,Hsien-Li Kao,Oriol Rodríguez-Leor,Elias Noory,Tiong Kiam Ong,Thierry Unterseeh,Pedro de Araújo Gonçalves,Andreas Zirlik,Khaled Almerri,Faisal Sharif,Lucas Lauder,M. Wanten,Martin Fahy,Michael Böhm +21 more
TL;DR: In this paper , the impact of catheter-based Renal Denervation (RDN) on TTR and its association with cardiovascular outcomes in the GSR (Global SymPLICITY Registry) was evaluated.
Journal ArticleDOI
Comprehensive assessment of hypertensive heart disease: cardiac magnetic resonance in focus.
Marijana Tadic,Cesare Cuspidi,Sven Plein,Isidora Grozdic Milivojevic,Dao Wen Wang,Guido Grassi,Giuseppe Mancia +6 more
TL;DR: The aim of this review is to summarize the current knowledge regarding CMR techniques and their potential usage in patients with hypertensive heart disease.
Journal ArticleDOI
Clinical management of resistant hypertension: practical recommendations from the Italian Society of Hypertension (SIIA)
TL;DR: Practical recommendations for the proper diagnosis and management of resistant hypertension are summarized, targeting both the general practitioner and the specialist who play an active role in the clinical management of patients with arterial hypertension.
Journal ArticleDOI
The management of the type 2 diabetic patient with hypertension - too late and too little: suggested improvements.
Lars Rydén,Bernard Waeber,Luis M. Ruilope,Giuseppe Mancia,Massimo Volpe,Heinrich Holzgreve,Carl Erik Mogensen,Stéphane Laurent +7 more
TL;DR: The need for more aggressive management strategies for patients with comorbid hypertension and type 2 diabetes, regardless of their baseline blood pressure, is suggested, including the early use of combination therapy with blockers of the renin–angiotensin system.
Journal ArticleDOI
White-Coat Hypertension: the Neglected Subgroup in Hypertension
TL;DR: A number of issues concerning WCH are addressed with particular attention to prevalence and clinical correlates, relation with subclinical target organ damage and CV morbidity/mortality, therapeutic perspectives.